Evidence map›Paper›PMID 42222216›Full record

ArticleExperimental and therapeutic medicine2026

Intravenous leiomyomatosis of the uterus: A case report and literature review.

Yuzhen Zhao, Fei Tian

Abstract readCase Reports
In one paragraph

Article in Experimental and therapeutic medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yuzhen ZhaoGraduate School of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China.
Fei TianDepartment of Gynecology, Hebei General Hospital, Shijiazhuang, Hebei 050000, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intravenous leiomyomatosis (IVL) is a rare benign ovarian tumor that predominantly affects women of reproductive and perimenopausal age, and is often accompanied by uterine fibroids. Patients typically present with symptoms such as menorrhagia, anemia, dysmenorrhea, abdominal pain or a palpable abdominal mass. In its early stages, the clinical manifestations of this disease are highly nonspecific and lack typical features, leading to a high rate of underdiagnosis or misdiagnosis in clinical practice. IVL is classified as a borderline tumor due to its histologically benign characteristics but biologically malignant behaviors, such as vascular invasion and distant spread. When the lesion extends to involve the inferior vena cava or even the heart, recurrent syncope may become the predominant clinical manifestation. With disease progression, sudden cardiac arrest of a fatal type may occur. Surgical resection remains the primary treatment for this condition. Given its high recurrence rate, post-operative follow-up should be conducted in a manner similar to that for malignant tumors, with regular imaging surveillance. To enhance clinical awareness of IVL, the present study describes a case of IVL in a patient whose chief complaint was increased menstrual flow, an atypical presentation. By reviewing the current case, practical insights may be provided into the diagnosis and management of IVL.

Indexed as

endocrine therapyintravenous leiomyomatosisleiomyosarcomaovarian tumor

Identifiers

PMID42222216
PMCPMC13216848

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.